My watch list
my.bionity.com  
Login  

Organic anion-transporting polypeptides (OATPs) mediate the hepatic uptake of many drugs. Hepatic uptake is crucial for the therapeutic effect of pravastatin, a cholesterol-lowering drug and OATP1A/1B substrate. We aimed to gain empirical insight into the relationship between OATPs and pravastatin pharmacokinetics and toxicity. We therefore compared the distribution and toxicity of pravastatin in wild-type and Oatp1a/1b-null mice. Intestinal absorption of pravastatin was not affected by Oatp1a/1b absence, but systemic plasma exposure (AUC) increased up to 30-fold after oral bolus administration. This increased plasma exposure resulted from reduced hepatic uptake, as evident from 10 to 100-fold lower liver-to-plasma concentration ratios. However, the reductions in liver exposure were far smaller (<2-fold) than the increases in plasma exposure. Reduced pravastatin liver uptake in Oatp1a/1b-null mice was more obvious shortly after intravenous administration, with 8-fold lower biliary pravastatin excretion. A...

Authors:   Dilek Iusuf; Rolf W. Sparidans; Anita van Esch; Mike Hobbs; Kathryn E. Kenworthy; Evita van de Steeg; Els Wagenaar; Jos H. Beijnen; Alfred H. Schinkel
Journal:   Molecular Pharmaceutics
Year:   2012
DOI:   10.1021/mp300108c
Publication date:   03-08-2012

Watchlist

This is where you can add this publication to your personal favourites.

Additional Information

Facts, background information, dossiers
More about American Chemical Society Publications
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE